We’re delighted to welcome leading healthcare consulting and advisory firm Avalere. The move marks the largest expansion of our company to date and allows clients to benefit from integrated offerings spanning value, evidence, access, and policy.

A healthcare consulting firm for more than 20 years based in Washington DC, Avalere partners with leading life sciences companies, health plans, providers, and investors to bring innovative, data-driven solutions to complex healthcare challenges.

The firm’s more than 200 advisors have a deep understanding of the US policy environment, with team members holding previous roles at Capitol Hill, Medicare and Medicaid services, and as lobbyists and in advocacy roles for key stakeholders. They are experts in federal policy, but also have capabilities spanning 50-state policy developments in all states. Alongside their policy expertise, they also offer extensive services in market access, transformation, and due diligence.

When leveraged alongside our capabilities in Europe, the US, Latin America, and the Asia-Pacific regions, Avalere Health offers unsurpassed global expertise and extensive insights across the product lifecycle.

“Avalere is renowned for helping clients identify business strategies that navigate the evolving healthcare landscape. From policy to market access and transformation, the team offers a 360-degree perspective that reflects the interconnected nature of the healthcare system,” says Jon Koch, CEO of Avalere Health. “Avalere complements our global footprint with a deep understanding of US markets and public policy, including key government and commercial stakeholders. We are excited to welcome Avalere.”

The deal marks another turning point in our journey. Starting out as a Medical Communications agency in 2001, we have developed into a global, full-service commercialization and healthcare advisory partner with services focused on evidence generation and access strategy, medical communications, scientific marketing, and strategic healthcare consulting.

Our capabilities are best-in-class individually but unite in seamless, integrated offerings based on each client’s unique challenge. Our services are underpinned by deep expertise in data and analytics, including proprietary applications in health economics and market access, and analytics-driven digital marketing.

A technology-enabled partnership

Our principal investor, Bridgepoint, acquired Avalere from Inovalon, a leading provider of cloud-based platforms that empower data-driven healthcare. The divestiture will allow both Inovalon and Avalere to focus on their respective missions and goals.

“This transaction will drive increased focus by both Inovalon and Avalere on our respective core differentiators,” says Dr. Keith Dunleavy, CEO of Inovalon. “At Inovalon, this focus is on providing the industry’s most advanced platform of cloud-based SaaS solutions empowering data-driven healthcare.”  Avalere will maintain access to Inovalon’s data resources, including the MORE2 Registry and 100% sample of Medicare Fee-for-Service (FFS) dataset. The MORE2 Registry is comprised of data on more than 1 million physicians, almost 600,000 clinical facilities, 348 million unique patients, and 68 billion medical events.

Avalere’s Health Economics & Advanced Analytics practice will remain within Inovalon as the Data Solutions segment of Inovalon Insights Business Unit and continue to focus on analytics leveraging Inovalon’s proprietary data assets.

An exciting, shared future for employees, clients, and customers

“Avalere is excited to combine our deep understanding of the US market with a truly global perspective,” says Elizabeth Carpenter, President of Avalere. “We look forward to collaborating and innovating with our new colleagues and offering our clients a broader set of integrated services.”

At Avalere Health, we have built a diverse and inclusive culture that nurtures collaboration. Our collective teams imagine a healthier world and build the connections to make it happen, providing innovative solutions to the most complex healthcare challenges.

This article was originally published on June 7, 2022.